Inventor · disambiguated record
Tejal Parekh
Also filed as: PAREKH TEJAL
8 granted patents·3 pending applications·695 citations·filing 2001–2011
91Inventor score
Top patents by PatentIndex Score
11 records- 0198US6838475B2Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jan 4, 2005·121 cites·43 claims
- 0297US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0396US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0495US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0595US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 0694US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 0789USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 0857US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 0953US2011117057A1Novel peptides as ns3-serine protease inhibitors of hepatitis c virusSCHERING CORP·Filed 2010·Application pending·0 cites
- 1053US2005059606A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2004·Application pending·0 cites
- 1151US7595299B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2005·Granted Sep 29, 2009·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Tejal Parekh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →